The Impact of US Food and Drug Administration’s Advisory and Enforcement Actions on US Sales of Esco Bars Products in 2023: Synthetic Control Approach
The FDA's advisory and enforcement actions substantially reduced sales of Esco Bars products in the United States, with a sustained impact noted over a 5-month period. These findings underscore the importance and impact of FDA actions against unauthorized tobacco products as part of a comprehensive regulatory approach.
Authors
- Matthew C. Farrelly (ORCID: https://orcid.org/0000-0002-6035-1596)
- Zachary Cahn (ORCID: https://orcid.org/0000-0001-5539-3604)
- Jonathan Hannings
- Brian A King
- Robin Toblin
- Xin Xu
- Hyungsik Shin
Institutions
- United States Food and Drug Administration (US)
- Center for Drug Evaluation and Research (US)
Publication Details
- Journal
- JMIR Public Health and Surveillance
- Published
- 2026-03-12
- DOI
- https://doi.org/10.2196/81033
- Primary Topic
- Smoking Behavior and Cessation
- Type
- article
- Field-Weighted Citation Impact
- 0.00